ADAM17 and nasopharyngeal carcinoma: In nasopharyngeal carcinoma cells, miR-145 expression was likewise significantly downregulated, whereas ADAM17 protein expression was upregulated, and ADAM17 had been verified as a target of miR-145 [54].